Midatech Pharma US enrols first patient in Gelclair® trial in stem cell transplant Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focussed on developing ...
Jaguar planning to begin commercial launch of FDA-approved Gelclair ® prescription gel for oral mucositis (also called “chemo mouth”) in Q3 2024 Company to feature “Make Cancer Less Shitty” patient ...
Catherine Miller Collis was instrumental in bringing about Jaguar's recent in-license agreement for FDA-approved Gelclair ®, a protective gel for management of oral mucositis, a common, painful, and ...
Oral mucositis, also called "chemo mouth," has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task force Up to 40% of all patients ...
Oral mucositis, also called "chemo mouth," has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task force Top line results imminent for ...
SAN FRANCISCO, CA / ACCESSWIRE / October 16, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that Jaguar family company Napo Pharmaceuticals ("Napo") has initiated the commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results